Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Lee

Showing results (341-350 of 365) with videos related to

Pageof 37
Sort By:
Nature Communications|February 7, 2026
Pan-RAF inhibitor exarafenib targets BRAF class II/III NSCLC and reveals ARAF-KSR1 resistance and combination strategiesTadashi Manabe, Hannah C Bergo, Qingtian Li, et al.
Research Square|November 24, 2025
Targeting BRAF Class II and III Mutations in NSCLC with the pan-RAF inhibitor Exarafenib Reveals ARAF-KSR1-Mediated Resistance and Rational Combination StrategiesTadashi Manabe, Hannah C Bergo, Qingtian Li, et al.
Current Epidemiology Reports|September 13, 2023
Challenges and Opportunities of Epidemiological Studies to Reduce the Burden of Cancers in Young AdultsHazel B Nichols, Karen J Wernli, Neetu Chawla, et al.
Annals of Surgical Oncology|November 13, 2024
Society of Surgical Oncology Breast Disease Site Working Group Statement on Bilateral Risk-Reducing Mastectomy: Indications, Outcomes, and RisksPuneet Singh, Doreen M Agnese, Miral Amin, et al.
JAMA Cardiology|October 5, 2022
Association of Thoracic Aortic Aneurysm Size With Long-term Patient Outcomes: The KP-TAA StudyMatthew D Solomon, Thomas Leong, Sue Hee Sung, et al.
Annals of Surgical Oncology|July 12, 2024
Clipping the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical TrialKayla M Switalla, Judy C Boughey, Katrina Dimitroff, et al.
Transplantation and Cellular Therapy|July 4, 2025
Assessing cognitive function in transplantation and chimeric antigen receptor t cell therapy recipients: Expert recommendations from the survivorship, aging and biobehavioral special interest groups of the American Society for Transplantation and Cellular TherapyVanessa E Kennedy, Nausheen Ahmed, Andy Artz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2026
Randomized, Placebo-Controlled Trial of B-Cell Depletion for Prevention of Corticosteroid-Requiring Chronic Graft-Versus-Host DiseaseCorey Cutler, Haesook T Kim, Hassan El Banna, et al.
Annals of Surgery|June 16, 2023
Breast Conservation Surgery and Mastectomy Have Similar Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From 1462 Patients on the Prospective, Randomized I-SPY2 TrialRita A Mukhtar, Harrison Chau, Hannah Woriax, et al.
Annals of Surgical Oncology|July 24, 2025
Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical TrialRita A Mukhtar, Katrina Dimitroff, Christina Yau, et al.
Pageof 37

Showing results (341-350 of 365) with videos related to

Sort By:
Pageof 37
Nature Communications|February 7, 2026
Pan-RAF inhibitor exarafenib targets BRAF class II/III NSCLC and reveals ARAF-KSR1 resistance and combination strategiesTadashi Manabe, Hannah C Bergo, Qingtian Li, et al.
Research Square|November 24, 2025
Targeting BRAF Class II and III Mutations in NSCLC with the pan-RAF inhibitor Exarafenib Reveals ARAF-KSR1-Mediated Resistance and Rational Combination StrategiesTadashi Manabe, Hannah C Bergo, Qingtian Li, et al.
Current Epidemiology Reports|September 13, 2023
Challenges and Opportunities of Epidemiological Studies to Reduce the Burden of Cancers in Young AdultsHazel B Nichols, Karen J Wernli, Neetu Chawla, et al.
Annals of Surgical Oncology|November 13, 2024
Society of Surgical Oncology Breast Disease Site Working Group Statement on Bilateral Risk-Reducing Mastectomy: Indications, Outcomes, and RisksPuneet Singh, Doreen M Agnese, Miral Amin, et al.
JAMA Cardiology|October 5, 2022
Association of Thoracic Aortic Aneurysm Size With Long-term Patient Outcomes: The KP-TAA StudyMatthew D Solomon, Thomas Leong, Sue Hee Sung, et al.
Annals of Surgical Oncology|July 12, 2024
Clipping the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical TrialKayla M Switalla, Judy C Boughey, Katrina Dimitroff, et al.
Transplantation and Cellular Therapy|July 4, 2025
Assessing cognitive function in transplantation and chimeric antigen receptor t cell therapy recipients: Expert recommendations from the survivorship, aging and biobehavioral special interest groups of the American Society for Transplantation and Cellular TherapyVanessa E Kennedy, Nausheen Ahmed, Andy Artz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2026
Randomized, Placebo-Controlled Trial of B-Cell Depletion for Prevention of Corticosteroid-Requiring Chronic Graft-Versus-Host DiseaseCorey Cutler, Haesook T Kim, Hassan El Banna, et al.
Annals of Surgery|June 16, 2023
Breast Conservation Surgery and Mastectomy Have Similar Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From 1462 Patients on the Prospective, Randomized I-SPY2 TrialRita A Mukhtar, Harrison Chau, Hannah Woriax, et al.
Annals of Surgical Oncology|July 24, 2025
Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical TrialRita A Mukhtar, Katrina Dimitroff, Christina Yau, et al.
Pageof 37